Clinical Trial Update: Efficacy and Safety of Tocilizumab in Adult's Still Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results evaluating the efficacy and safety of tocilizumab in adults with adult-onset Still's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Still Disease

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Adult's Still Disease | Phase 2 | Status: UNKNOWN